Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug PipelineGlobeNewsWire • 12/20/23
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology CandidateGlobeNewsWire • 12/04/23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating ResultsGlobeNewsWire • 11/14/23
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseasesBusiness Wire • 11/14/23
Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan CohenGlobeNewsWire • 09/21/23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating ResultsGlobeNewsWire • 08/14/23
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business OfficerGlobeNewsWire • 08/14/23
Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine DevelopmentGlobeNewsWire • 08/10/23
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI SummitGlobeNewsWire • 06/15/23
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of PhilipsGlobeNewsWire • 06/06/23
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/15/23
Absci Reports Business Updates and First Quarter 2023 Financial and Operating ResultsGlobeNewsWire • 05/15/23
University of Oxford's Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven ImmunotherapiesGlobeNewsWire • 05/11/23
Absci Corporation (ABSI) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 05/03/23
Absci to Participate in the 22nd Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/06/23
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating ResultsGlobeNewsWire • 03/30/23
Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug CreationGlobeNewsWire • 03/23/23
Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor ForumGlobeNewsWire • 03/07/23